Cart
sales@molnova.com
Rabeprazole Related Compound E
CAS No. 117977-21-6
Rabeprazole Related Compound E( Rabeprazole thioether | Rabeprazole impurity E )
Catalog No. M10610 CAS No. 117977-21-6
Rabeprazole is an antiulcer drug in the class of proton pump inhibitors.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | 28 | In Stock |
|
| 500MG | 41 | In Stock |
|
| 1G | 57 | In Stock |
|
Biological Information
-
Product NameRabeprazole Related Compound E
-
NoteResearch use only, not for human use.
-
Brief DescriptionRabeprazole is an antiulcer drug in the class of proton pump inhibitors.
-
DescriptionRabeprazole is an antiulcer drug in the class of proton pump inhibitors.
-
In Vitro——
-
In Vivo——
-
SynonymsRabeprazole thioether | Rabeprazole impurity E
-
PathwayMembrane Transporter/Ion Channel
-
TargetProton Pump
-
RecptorProton pump
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number117977-21-6
-
Formula Weight343.44
-
Molecular FormulaC18H21N3O2S
-
Purity>98% (HPLC)
-
SolubilityLimited solubility
-
SMILESCOCCCOC1=C(C)C(CSC2=NC3=CC=CC=C3N2)=NC=C1
-
Chemical Name2-(((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methyl)thio)-1H-benzo[d]imidazole
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ohara T, et al. Helicobacter. 2001 Jun;6(2):125-9.
molnova catalog
related products
-
CS-526
CS-526 (AKU 517;R 105266) is a potent, competitive, and reversible acid pump antagonist (potassium-competitive acid blocker) that inhibits H+,K+-ATPase activity with IC50 of 61 nM.
-
Pantoprazole
A proton pump inhibitor that inhibits gastric acid secretion; works on gastric parietal cells to irreversibly inhibit (H+/K+)-ATPase function and suppress the production of gastric acid.
-
Levolansoprazole
Levolansoprazole, a proton pump inhibitor, irreversibly inhibits H+/K+-stimulated ATPase pumps in parietal cells (IC50: 5.2 μM).
